CAJ | 학술논문

目的探讨内镜黏膜下挖除术(ESE)治疗胃固有肌层肿瘤的安全性及疗效.方法以2006年7月至2011年3月期间浙江省台州医院对起源于胃固有肌层的黏膜下肿瘤而行ESE治疗的116例患者为研究对象,分析术中、术后并发症及相应治疗情况,术后对上述病例进行胃镜随访.结果成功挖除肿瘤112例(96.6％),手术时间(51.9±16.3)min.术中出血9例(7.8％),术中穿孔20例(17.2％),术后出血3例(2.6％),需外科干预5例(4.3％),其中术中4例,术后1例.术后未出现腹腔脓肿,腹膜炎等其他并发症;ESE术后平均住院6.1 d;中位随访时间12个月,随访期内未发现肿瘤残留及复发.结论 ESE治疗胃固有肌层肿瘤是安全可行的,近期疗效确切.
목적 탐토내경점막하알제술(ESE)치료위고유기층종류적안전성급료효.방법 이2006년7월지2011년3월기간절강성태주의원대기원우위고유기층적점막하종류이행ESE치료적116례환자위연구대상,분석술중、술후병발증급상응치료정황,술후대상술병례진행위경수방.결과 성공알제종류112례(96.6％),수술시간(51.9±16.3)min.술중출혈9례(7.8％),술중천공20례(17.2％),술후출혈3례(2.6％),수외과간예5례(4.3％),기중술중4례,술후1례.술후미출현복강농종,복막염등기타병발증;ESE술후평균주원6.1 d;중위수방시간12개월,수방기내미발현종류잔류급복발.결론 ESE치료위고유기층종류시안전가행적,근기료효학절.
Objective To explore the efficacy and safety of endoscopic submucosal enucleation(ESE)for gastric submucosal tumors(SMTs)originated from muscularis propria.Methods A total of 116 patients with gastric SMT originated from muscularis propria underwent ESE in Department of Gastroenterology of the Taizhou Hospital between July 2006 and March 2011.The occurrence of intraoperative and post-operative complications and corresponding treatment were recorded.After the treatment of ESE,the patients were followed up endoscopically.Results The success rate of operation was 96.6％.The mean time of the procedure was(51.9±16.3)min.Complications included intraoperative bleeding(n=9,7.8％),perforation(n=20,17.2％),and post-operative bleeding(n=3,2.6％).Among them,5 cases(4.3％)required surgical intervention.None of patient had other complications such as peritoneal abscess or peritonitis.The mean hospitalization time after ESE was 6.1 days.The median follow-up period was 12 months(range,3-48 months)and there was no residual tumor or recurrence.Conclusion ESE is a safe and feasible treatment for patients with gastric SMT originated from muscularis propria.